Literature DB >> 29055143

Pasireotide for the treatment of refractory hypoglycaemia from malignant insulinoma.

Nicholas S Hendren1, Kamaldeep Panach2, Timothy J Brown1, Lan Peng3, Muhammad S Beg4, Jonathan Weissler5, Sasan Mirfakhraee2.   

Abstract

Entities:  

Keywords:  insulinoma; lanreotide; octreotide; pasireotide; pituitary

Mesh：

Substances：

Year:  2017        PMID： 29055143     DOI： 10.1111/cen.13503

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  9 in total

Review 1.  The functioning side of the pancreas: a review on insulinomas.

Authors:  I Maggio; V Mollica; N Brighi; G Lamberti; L Manuzzi; A D Ricci; D Campana
Journal:  J Endocrinol Invest       Date:  2019-07-31       Impact factor: 4.256

Review 2.  Malignant insulinoma: Can we predict the long-term outcomes?

Authors:  Maja Cigrovski Berkovic; Monika Ulamec; Sonja Marinovic; Ivan Balen; Anna Mrzljak
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

3.  Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2020-11-11       Impact factor: 3.889

Review 4.  Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations.

Authors:  Benjamin Chevalier; Hippolyte Dupuis; Arnaud Jannin; Madleen Lemaitre; Christine Do Cao; Catherine Cardot-Bauters; Stéphanie Espiard; Marie Christine Vantyghem
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-06       Impact factor: 5.555

Review 5.  Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management.

Authors:  Francesca Spada; Roberta E Rossi; Elda Kara; Alice Laffi; Sara Massironi; Manila Rubino; Franco Grimaldi; Sherrie Bhoori; Nicola Fazio
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-04

Review 6.  Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms.

Authors:  Johannes Hofland; Gregory Kaltsas; Wouter W de Herder
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

7.  Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia.

Authors:  Mahwash Siddiqui; Amy Vora; Sadia Ali; Jessica Abramowitz; Sasan Mirfakhraee
Journal:  J Endocr Soc       Date:  2020-11-05

8.  Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion.

Authors:  Alexia Rouland; Benjamin Bouillet; Pauline Legris; Isabelle Simoneau; Jean-Michel Petit; Bruno Vergès
Journal:  Clin Pharmacol       Date:  2021-02-05

Review 9.  Multiple Endocrine Neoplasia Type 1: Latest Insights.

Authors:  Maria Luisa Brandi; Sunita K Agarwal; Nancy D Perrier; Kate E Lines; Gerlof D Valk; Rajesh V Thakker
Journal:  Endocr Rev       Date:  2021-03-15       Impact factor: 19.871
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.